Hindustan Times (Lucknow)

China’s Sinovac jab gets WHO’s nod

- Sutirtho Patranobis and Anirudh Bhattachar­yya letters@hindustant­imes.com

BEIJING/TORONTO: The World Health Organizati­on (WHO) has approved China’s Covid-19 vaccine made by Sinovac Biotech for emergency use, a statement from the UN health agency said on Tuesday, making it the second Chinese-produced shot to get the WHO’s nod.

“On the basis of available evidence, the WHO recommends the vaccine for use in adults 18 years and older, in a two-dose schedule with a spacing of two to four weeks,” the WHO said in a statement. Last month, the WHO had approved for emergency use a Covid-19 vaccine made by China’s state-owned drugmaker Sinopharm. It was the first developed by a non-Western country to win the WHO’s approval.

The WHO has also licensed vaccines developed by Pfizer-BioNTech, AstraZenec­a, Moderna and Johnson & Johnson.

In the US, Moderna has said that it has begun the process to secure full US regulatory approval for the use of its Covid-19 vaccine in adults. Moderna said it has begun a “rolling submission” to the Food and Drug Administra­tion (FDA) of data from its studies of the two-dose vaccine.

Canada to mix and match shots for easier roll-out

Canadian health authoritie­s have announced that Covid-19 vaccines will be mixed and matched, and the process could ensure a quicker roll-out of the national vaccinatio­n drive.

The announceme­nt from the Public Health Agency of Canada was based on an updated guidance from the National Advisory Committee on Immunizati­on (NACI), which recommende­d that a first dose of the AstraZenec­a vaccine, including the Covishield version manufactur­ed by the Serum Institute of India, could be followed by a second dose of either the Pfizer-BioNTech or Moderna vaccines.

Peru has more than doubled its official coronaviru­s death toll from around 69,300 to 180,700, becoming the country with the highest Covid-19 mortality per capita anywhere in the world.

Newspapers in English

Newspapers from India